Table 2.
Suspected MPX incidence in DRC (with and without the active surveillance areas), 2001–2013
Year | Incidence, per 100,000, 95% CI | Incidence per 100,000 (without active surveillance areas), 95% CI |
---|---|---|
2001 | 0.64 (0.09, 4.50) | 0.61 (0.09, 4.30) |
2002 | 1.4 (0.20, 9.90) | 0.94 (0.13, 6.70) |
2003 | 1.16 (0.16, 8.30) | 0.72 (0.10, 5.10) |
2004 | 1.53 (0.22, 10.90) | 0.82 (0.12, 5.80) |
2005 | 2.48 (0.35, 17.60) | 0.96 (0.13, 6.80) |
2006 | 1.11 (0.16, 7.80) | 0.67 (0.09, 4.80) |
2007 | 1.33 (0.19, 9.40) | 0.60 (0.08, 4.20) |
2008 | 2.13 (0.30, 15.10) | 1.00 (0.15, 7.40) |
2009 | 2.48 (0.35, 17.60) | 1.20 (0.17, 8.80) |
2010 | 2.91 (0.42, 20.70) | 1.40 (0.19, 9.60) |
2011 | 2.69 (0.38, 19.10) | 1.60 (0.23, 11.60) |
2012 | 3.11 (0.44, 22.10) | 2.00 (0.28, 14.40) |
2013 | 2.82 (0.40, 20.10) | 1.50 (0.22, 10.90) |